G01N 2333/988
Lyases
Official title: Lyases (4.), e.g. aldolases, heparinase, enolases, fumarase
G01N2333/988 (Lyases) appears on 210 US grants and 350 published applications in this corpus.
Search patents in G01N- Granted patents
- 210
- Published applications
- 350
- Assignees
- 238
- Inventors
- 726
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 4 | 0 |
| 2000 | 3 | 0 |
| 2001 | 6 | 5 |
| 2002 | 6 | 13 |
| 2003 | 5 | 19 |
| 2004 | 7 | 12 |
| 2005 | 5 | 13 |
| 2006 | 5 | 8 |
| 2007 | 1 | 6 |
| 2008 | 6 | 13 |
| 2009 | 4 | 7 |
| 2010 | 11 | 15 |
| 2011 | 8 | 14 |
| 2012 | 8 | 12 |
| 2013 | 2 | 13 |
| 2014 | 8 | 16 |
| 2015 | 15 | 21 |
| 2016 | 20 | 27 |
| 2017 | 9 | 16 |
| 2018 | 6 | 16 |
| 2019 | 17 | 9 |
| 2020 | 19 | 12 |
| 2021 | 4 | 10 |
| 2022 | 4 | 13 |
| 2023 | 6 | 8 |
| 2024 | 9 | 21 |
| 2025 | 6 | 17 |
| 2026 | 2 | 14 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- In vitro method for predicting mortality risk in patients suffering from shock28 Apr 2026US 12,614,637 B2Fundació Centre De Regulació GenòMica
- DNA repair blood test for predicting response of lung cancer patients to immunotherapy13 Jan 2026US 12,523,657 B2Yeda Research and Development Co. Ltd.
- Peptide ligand targeting carbonic anhydrase IX, peptide construct comprising same, and uses thereof2 Dec 2025US 12,486,304 B2C-Biomex Co., Ltd.
- MMP-8 as a marker for identifying infectious disease12 Aug 2025US 12,385,926 B2B.R.A.H.M.S GmbH
- Multi-protein biomarker assay for brain injury detection and outcome24 Jun 2025US 12,339,288 B2The Johns Hopkins University
- Potency assay matrix for neuronal cells24 Sep 2026US 2026/0287576 A1Aspen Neuroscience, Inc.
- Induced Pluripotent Stem Cell Model of Fibrous Dysplasia/Mccune-Albright Syndrome and Methods of Use10 Sep 2026US 2026/0266803 A1The Regents of the University of California
- Model for analyzing inflammation and uses thereof10 Sep 2026US 2026/0266804 A1Technion Research & Development Foundation Limited
- Methods for analyzing lung cancer associated proteomic markers27 Aug 2026US 2026/0251657 A1PrognomIQ, Inc.
- Methods for distinguishing lung cancer from non-cancer27 Aug 2026US 2026/0251663 A1PrognomIQ, Inc.
Most cited
By later US patents
- Methods of screening and diagnosing esophageal cancer by determining guanylin cyclase C expression105US 6,767,704 B2Thomas Jefferson University · 2004
- Polysaccharide conjugates of biomolecules91US 6,489,309 B1Dade Behring Marburg GmbH · 2002
- Compositions and methods for identifying and targeting cancer cells of alimentary canal origin84US 7,479,376 B2Thomas Jefferson University · 2009
- Enzymatic fluorometric assay for adenylate cyclase65US 5,618,665 ARegents of the University of Minnesota · 1997
- Enzymatic fluorometric assay for adenylate cyclase59US 5,316,907 ARegents of the University of Minnesota · 1994